Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru

Lucia Pallecchi, Monica Malossi, Antonia Mantella, Eduardo Gotuzzo, Christian Trigoso, Alessandro Bartoloni, Franco Paradisi, Göran Kronvall, Gian Maria Rossolini

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

A survey was carried out From August to November 2002 to evaluate the antimicrobial susceptibilities of fecal Escherichia coli isolates from 3,208 healthy children from four different urban areas of Latin America, two in Bolivia (Camiri and Villa Montes) and two in Peru (Yurimaguas and Moyobamba). Ceftriaxone-resistant E. coli isolates were detected in four children, one from each of the areas sampled. The isolates exhibited a multidrug-resistant phenotype, including resistance to oxyimino-cephalosporins and aztreonam, and the MICs of ceftazidime for the isolates were lower than those of cefotaxime. By PCR and sequencing, the blaCTX-M-2 determinant was detected in three isolates and the blaCTX-M-15 determinant was detected in one isolate (from Peru). The CTX-M-2-producing isolates belonged to three different phylogenetic groups (groups A, B2, and D), while the CTX-M-15-producing isolate belonged to phylogenetic group D. The blaCTX-M-2 determinants were transferable to E. coli by conjugation, while conjugative transfer of the blaCTX-M-2 determinant was not detectable. Plasmids harboring the blaCTX-M-2 determinant exhibited similar restriction profiles, and in all of them the gene was located on a 2.2-kb PstI fragment, suggesting a genetic environment similar to that present in In35 and InS21. The findings of the present study confirm the widespread distribution of CTX-M-type β-lactamases and underscore the role that commensal E. coli isolates could play as a potential reservoir of these clinically relevant resistance determinants. This is the first report of CTX-M-type enzymes in Bolivia and Peru and also the first report of the detection of CTX-M-15 in Latin America.

Original languageEnglish
Pages (from-to)4556-4561
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume48
Issue number12
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Bolivia
Peru
Escherichia coli
Latin America
Genes
Aztreonam
Ceftazidime
Cefotaxime
Ceftriaxone
Cephalosporins
Plasmids
Phenotype
Polymerase Chain Reaction
Enzymes
galantide

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. / Pallecchi, Lucia; Malossi, Monica; Mantella, Antonia; Gotuzzo, Eduardo; Trigoso, Christian; Bartoloni, Alessandro; Paradisi, Franco; Kronvall, Göran; Rossolini, Gian Maria.

In: Antimicrobial Agents and Chemotherapy, Vol. 48, No. 12, 12.2004, p. 4556-4561.

Research output: Contribution to journalArticle

Pallecchi, L, Malossi, M, Mantella, A, Gotuzzo, E, Trigoso, C, Bartoloni, A, Paradisi, F, Kronvall, G & Rossolini, GM 2004, 'Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru', Antimicrobial Agents and Chemotherapy, vol. 48, no. 12, pp. 4556-4561. https://doi.org/10.1128/AAC.48.12.4556-4561.2004
Pallecchi, Lucia ; Malossi, Monica ; Mantella, Antonia ; Gotuzzo, Eduardo ; Trigoso, Christian ; Bartoloni, Alessandro ; Paradisi, Franco ; Kronvall, Göran ; Rossolini, Gian Maria. / Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. In: Antimicrobial Agents and Chemotherapy. 2004 ; Vol. 48, No. 12. pp. 4556-4561.
@article{8c58e13539d943f6945712f7c04e19d2,
title = "Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru",
abstract = "A survey was carried out From August to November 2002 to evaluate the antimicrobial susceptibilities of fecal Escherichia coli isolates from 3,208 healthy children from four different urban areas of Latin America, two in Bolivia (Camiri and Villa Montes) and two in Peru (Yurimaguas and Moyobamba). Ceftriaxone-resistant E. coli isolates were detected in four children, one from each of the areas sampled. The isolates exhibited a multidrug-resistant phenotype, including resistance to oxyimino-cephalosporins and aztreonam, and the MICs of ceftazidime for the isolates were lower than those of cefotaxime. By PCR and sequencing, the blaCTX-M-2 determinant was detected in three isolates and the blaCTX-M-15 determinant was detected in one isolate (from Peru). The CTX-M-2-producing isolates belonged to three different phylogenetic groups (groups A, B2, and D), while the CTX-M-15-producing isolate belonged to phylogenetic group D. The blaCTX-M-2 determinants were transferable to E. coli by conjugation, while conjugative transfer of the blaCTX-M-2 determinant was not detectable. Plasmids harboring the blaCTX-M-2 determinant exhibited similar restriction profiles, and in all of them the gene was located on a 2.2-kb PstI fragment, suggesting a genetic environment similar to that present in In35 and InS21. The findings of the present study confirm the widespread distribution of CTX-M-type β-lactamases and underscore the role that commensal E. coli isolates could play as a potential reservoir of these clinically relevant resistance determinants. This is the first report of CTX-M-type enzymes in Bolivia and Peru and also the first report of the detection of CTX-M-15 in Latin America.",
author = "Lucia Pallecchi and Monica Malossi and Antonia Mantella and Eduardo Gotuzzo and Christian Trigoso and Alessandro Bartoloni and Franco Paradisi and G{\"o}ran Kronvall and Rossolini, {Gian Maria}",
year = "2004",
month = "12",
doi = "10.1128/AAC.48.12.4556-4561.2004",
language = "English",
volume = "48",
pages = "4556--4561",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru

AU - Pallecchi, Lucia

AU - Malossi, Monica

AU - Mantella, Antonia

AU - Gotuzzo, Eduardo

AU - Trigoso, Christian

AU - Bartoloni, Alessandro

AU - Paradisi, Franco

AU - Kronvall, Göran

AU - Rossolini, Gian Maria

PY - 2004/12

Y1 - 2004/12

N2 - A survey was carried out From August to November 2002 to evaluate the antimicrobial susceptibilities of fecal Escherichia coli isolates from 3,208 healthy children from four different urban areas of Latin America, two in Bolivia (Camiri and Villa Montes) and two in Peru (Yurimaguas and Moyobamba). Ceftriaxone-resistant E. coli isolates were detected in four children, one from each of the areas sampled. The isolates exhibited a multidrug-resistant phenotype, including resistance to oxyimino-cephalosporins and aztreonam, and the MICs of ceftazidime for the isolates were lower than those of cefotaxime. By PCR and sequencing, the blaCTX-M-2 determinant was detected in three isolates and the blaCTX-M-15 determinant was detected in one isolate (from Peru). The CTX-M-2-producing isolates belonged to three different phylogenetic groups (groups A, B2, and D), while the CTX-M-15-producing isolate belonged to phylogenetic group D. The blaCTX-M-2 determinants were transferable to E. coli by conjugation, while conjugative transfer of the blaCTX-M-2 determinant was not detectable. Plasmids harboring the blaCTX-M-2 determinant exhibited similar restriction profiles, and in all of them the gene was located on a 2.2-kb PstI fragment, suggesting a genetic environment similar to that present in In35 and InS21. The findings of the present study confirm the widespread distribution of CTX-M-type β-lactamases and underscore the role that commensal E. coli isolates could play as a potential reservoir of these clinically relevant resistance determinants. This is the first report of CTX-M-type enzymes in Bolivia and Peru and also the first report of the detection of CTX-M-15 in Latin America.

AB - A survey was carried out From August to November 2002 to evaluate the antimicrobial susceptibilities of fecal Escherichia coli isolates from 3,208 healthy children from four different urban areas of Latin America, two in Bolivia (Camiri and Villa Montes) and two in Peru (Yurimaguas and Moyobamba). Ceftriaxone-resistant E. coli isolates were detected in four children, one from each of the areas sampled. The isolates exhibited a multidrug-resistant phenotype, including resistance to oxyimino-cephalosporins and aztreonam, and the MICs of ceftazidime for the isolates were lower than those of cefotaxime. By PCR and sequencing, the blaCTX-M-2 determinant was detected in three isolates and the blaCTX-M-15 determinant was detected in one isolate (from Peru). The CTX-M-2-producing isolates belonged to three different phylogenetic groups (groups A, B2, and D), while the CTX-M-15-producing isolate belonged to phylogenetic group D. The blaCTX-M-2 determinants were transferable to E. coli by conjugation, while conjugative transfer of the blaCTX-M-2 determinant was not detectable. Plasmids harboring the blaCTX-M-2 determinant exhibited similar restriction profiles, and in all of them the gene was located on a 2.2-kb PstI fragment, suggesting a genetic environment similar to that present in In35 and InS21. The findings of the present study confirm the widespread distribution of CTX-M-type β-lactamases and underscore the role that commensal E. coli isolates could play as a potential reservoir of these clinically relevant resistance determinants. This is the first report of CTX-M-type enzymes in Bolivia and Peru and also the first report of the detection of CTX-M-15 in Latin America.

UR - http://www.scopus.com/inward/record.url?scp=9644279634&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9644279634&partnerID=8YFLogxK

U2 - 10.1128/AAC.48.12.4556-4561.2004

DO - 10.1128/AAC.48.12.4556-4561.2004

M3 - Article

VL - 48

SP - 4556

EP - 4561

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 12

ER -